Management of Immune Checkpoint Inhibitor-Induced Myocarditis: The French Working Group's Plea for a Pragmatic Approach

Affiliations

• ¹ French Institute of Health and Medical Research 1263, National Institute of Agricultural Research, Centre for CardioVascular and Nutrition Research, Unit of Heart Failure and Valvular Heart Diseases, Department of Cardiology, University Mediterranean Centre of Cardio-Oncology, Nord Hospital, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille University, Marseille, France.
• ² Mediterranean Group of Cardio-Oncology, Marseille, France.
• ³ PICARO Cardio-oncology Program, Department of Pharmacology, Department of Cardiology, Caen Hospital, Medical School, University of Caen Normandy, Caen, France.
• ⁴ UNICO-GRECO Cardio-Oncology Program, Centre d'Investigation Clinique Paris-Est, Department of Pharmacology, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University, Paris, France.
• ⁵ Unit of Cardio-Oncology and Prevention, European Georges Pompidou Hospital, Assistance Publique-Hôpitaux de Paris, Paris University, Paris, France.
• ⁶ UMR-S 942, Department of Cardiology, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Paris University, Paris, France.
• ⁷ French Institute of Health and Medical Research 856, UNICO-GRECO Cardio-Oncology Program, Department of Cardiology, Saint-Antoine Hospital and Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University, Paris, France.